1 results match your criteria: "and Pathology Medical University Vienna[Affiliation]"
'Blind' antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa.
Ann Oncol
March 2006
Departments of Medicine I, Division of Oncology, Opththalmology, and Pathology Medical University Vienna, Vienna, Austria.
Background: Recent results have implicated Chlamydia, especially Chlamydia psittaci, in the development of ocular adnexal lymphoma in the large majority of patients. We present our experience with ex-juvantibus antibiotic treatment in patients diagnosed with MALT lymphoma of the ocular adnexa.
Patients And Methods: A retrospective analysis identified a total of 11 patients (six female, five male) with MALT-lymphoma of the ocular adnexa who were given doxycyclin 200 mg p.